Cargando…
Enantioselective Resolution of (R,S)-Carvedilol to (S)-(−)-Carvedilol by Biocatalysts
Among the microorganisms employed in the study, Aspergillus niger (GUFCC5443), Escherichia coli (ATCC9637), Streptomyces halstedii (CKM-2), Pseudomonas putida (NCIB9494), Cunninghamella elegans (NCIM689) and Sphingomonas paucimobilis (NCTC11030) were capable for the enantioselective conversion of ra...
Autores principales: | Ettireddy, Swetha, Chandupatla, Vijitha, Veeresham, Ciddi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315674/ https://www.ncbi.nlm.nih.gov/pubmed/28064425 http://dx.doi.org/10.1007/s13659-016-0118-2 |
Ejemplares similares
-
Carvedilol in hypertension treatment
por: Stafylas, Panagiotis C, et al.
Publicado: (2008) -
Carvedilol—NSBB of Choice in All Cirrhotics? Short Title: Carvedilol for Portal Hypertension
por: Tandon, Puneeta, et al.
Publicado: (2015) -
Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007) -
Use of carvedilol in hypertension: an update
por: Leonetti, Gastone, et al.
Publicado: (2012) -
Carvedilol in the Treatment of Portal Hypertension
por: Al-Ghamdi, Hamdan
Publicado: (2011)